Outset Medical, Inc. - Common Stock (NQ:OM)

4.105 +0.145 (+3.66%)

Delayed Quote Updated: 12:45 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Outset Medical, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Outset Medical to Present at the BofA Securities 2022 Healthcare Conference

April 26, 2022

From Outset Medical, Inc.

Via Business Wire

Outset Medical Names Business Leader Dale E. Jones to Board of Directors

April 25, 2022

From Outset Medical, Inc.

Via Business Wire

Outset Medical to Report First Quarter 2022 Financial Results on Wednesday, May 4, 2022

April 20, 2022

From Outset Medical, Inc.

Via Business Wire

Outset Medical Presents New Data on Home Dialysis at National Kidney Foundation Spring Meetings

April 06, 2022

From Outset Medical, Inc.

Via Business Wire

Outset Medical More Than Doubles Sales In FY21, Issues Better Than Expected FY22 Outlook ↗

February 17, 2022

Via Benzinga

Recap: Outset Medical Q4 Earnings ↗

February 17, 2022

Outset Medical (NASDAQ:OM) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

February 22, 2022

From Outset Medical, Inc.

Via Business Wire

60 Biggest Movers From Yesterday ↗

February 18, 2022

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares climbed 618.2% to close at $92.65 on Thursday, just a few days after the company completed its SPAC merger with Thayer...

Via Benzinga

Earnings Scheduled For February 16, 2022 ↗

February 16, 2022

Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million.

Via Benzinga

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗

February 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...

Via Benzinga

Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results

February 16, 2022

From Outset Medical, Inc.

Via Business Wire

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa ↗

February 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...

Via Benzinga

Earnings Preview For Outset Medical ↗

February 15, 2022

Outset Medical (NASDAQ:OM) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that Outset...

Via Benzinga

Outset Medical to Present at SVB Leerink Global Healthcare Conference

February 04, 2022

From Outset Medical, Inc.

Via Business Wire

Outset Medical to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 16, 2022

February 02, 2022

From Outset Medical, Inc.

Via Business Wire

The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout ↗

November 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-...

Via Benzinga

Outset Medical's Tablo Hemodialysis System Cartridge Receives FDA Approval For Manufacturing In North America ↗

November 30, 2021

The FDA has granted 510(k) clearance for Outset Medical Inc's (NASDAQ: OM) new sterilization method of the cartridge utilized in its Tablo Hemodialysis...

Via Benzinga

Tablo® Hemodialysis System Cartridge Receives FDA 510(k) Clearance Enabling Production in North America

November 29, 2021

From Outset Medical, Inc.

Via Business Wire

Outset Medical Named to Fast Company’s First-Ever List of the Next Big Things in Tech

November 18, 2021

From Outset Medical, Inc.

Via Business Wire

Outset Medical Launches Inaugural ESG Report

November 08, 2021

From Outset Medical, Inc.

Via Business Wire

Outset Medical Inc (OM) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

OM earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Outset Medical Reports Third Quarter 2021 Financial Results

November 03, 2021

From Outset Medical, Inc.

Via Business Wire

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

Outset Medical to Present at Stifel 2021 Virtual Health Care Conference

November 02, 2021

From Outset Medical, Inc.

Via Business Wire

Outset Medical’s Tablo® Hemodialysis System Receives Landmark TPNIES Approval From CMS

November 01, 2021

From Outset Medical, Inc.

Via Business Wire

Outset Medical to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021

October 20, 2021

From Outset Medical, Inc.

Via Business Wire

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Outset Medical's Return On Capital Employed Insights ↗

September 06, 2021

Outset Medical (NASDAQ:OM) brought in sales totaling $25.22 million during Q2 according to data provided by Benzinga Pro.However, earnings decreased 0.78%, resulting in a loss of...

Via Benzinga

1 Beaten-Down Healthcare Stock to Put on Your Radar ↗

September 05, 2021

This innovative company is well off its highs and could be worth a look.

Via The Motley Fool

2 Beaten Down Stocks With 10X Potential ↗

September 01, 2021

While there's no way to accurately predict the future, these stocks have a chance to produce tremendous returns if things go well.

Via The Motley Fool

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.